发明申请
US20120245085A1 Pharmaceutical Solution of Non Covalently Bound Albumin and Acylated Insulin
有权
非共价结合的白蛋白和酰化胰岛素的药物溶液
- 专利标题: Pharmaceutical Solution of Non Covalently Bound Albumin and Acylated Insulin
- 专利标题(中): 非共价结合的白蛋白和酰化胰岛素的药物溶液
-
申请号: US13505188申请日: 2010-11-01
-
公开(公告)号: US20120245085A1公开(公告)日: 2012-09-27
- 发明人: Helle Naver , Svend Havelund , Peter Madsen
- 申请人: Helle Naver , Svend Havelund , Peter Madsen
- 申请人地址: DK Bagsvaerd
- 专利权人: Novo Nordisk A/S
- 当前专利权人: Novo Nordisk A/S
- 当前专利权人地址: DK Bagsvaerd
- 优先权: EP09174762.6 20091102; EP10173750.0 20100823
- 国际申请: PCT/EP10/66553 WO 20101101
- 主分类号: A61K38/38
- IPC分类号: A61K38/38
摘要:
If albumin is added to a pharmaceutical formulation containing acylated insulin described in WO 2009/022005 and WO 2009/022013, the acylated insulin can be kept in solution after subcutaneous injection.